Endra Life SciencesNDRA
13F holders, Q4 2024 (December 31)4holders
$6.26avg. 13F price*
At the end of Q4 2024, 4 institutions reported holding Endra Life Sciences Inc. (NDRA) in their 13F filings. The largest holders were UBS Group AG ($595), Morgan Stanley ($81) and Bank of America Corp. ($25).
- Company
- Endra Life Sciences Inc.
- CUSIP
- 29273B500
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $720 |
| Exits | 0 | $0 |
Ownership 4 holders
| UBS Group AG | 0.00% | New | 95 | $595 |
| Morgan Stanley | 0.00% | New | 13 | $81 |
| Bank of America Corp. | 0.00% | New | 4 | $25 |
| Danske Bank A/S | 0.00% | New | 3 | $19 |
"% of holder's portfolio" is NDRA's weight in each manager's 13F, not the share of Endra Life Sciences Inc. the manager owns.